Member

The major issue associated with weight loss drugs is the effect that such rapid weight loss can have on the face. Patients are presenting with problems such as sunken eyes, sagging jowls, and a loss of facial volume resulting in hollow cheeks and changes to the lips and chin. And whilst most Ozempic patients are initially pleased to have a slimmer face, this reduction in facial volume can be very ageing.

Timing of Esthetic Interventions

A central challenge is determining the optimal timing for esthetic interventions in patients using GLP‐1 agonists. Should treatments be initiated early during the weight loss process to prevent esthetic issues, or should practitioners wait until weight stabilization, perhaps 3, 6, or 9 months after weight loss?